Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 771
Filtrar
1.
Andes Pediatr ; 92(1): 42-49, 2021 Feb.
Artículo en Inglés, Español | MEDLINE | ID: mdl-34106182

RESUMEN

INTRODUCTION: Impulse oscillometry (IOS) is useful for measuring lung function in preschool children. Our objec tive was to describe the alterations and evolutionary profile of IOS in asthmatic children under 6 years of age after one year of follow-up. PATIENTS AND METHOD: 62 preschoolers performed IOS at the begin ning of the study and after one year. The proportion of altered IOS and bronchodilator response (BR +) at both times was compared, in addition to sub-analysis according to asthma control and presence of atopy. For the statistical analysis, we used McNemar's %2 and the Student's t-test with a 5% a error. RESULTS: The initial IOS was altered in 80.6% and in 64.5%% after one year (p = 0.04). 77.4% of the children presented BR+ at the beginning of the study and 83.9% after one year. The uncontrolled asthma group presented a significant improvement in the X5 and D5-20 means, but the controlled asthma group did not. In atopic patients, only uncontrolled asthmatics improved X5, AX, and D5-20. CONCLUSION: IOS shows alterations in a high percentage of preschoolers with uncontrolled asthma, which decreases significantly at one year, but remains altered and with BR + in most children. Ad ditional studies are required to identify different preschool asthma phenotypes and their evolution with treatment.


Asunto(s)
Asma/fisiopatología , Pulmón/fisiopatología , Corticoesteroides/uso terapéutico , Asma/tratamiento farmacológico , Broncodilatadores/uso terapéutico , Preescolar , Femenino , Humanos , Hipersensibilidad Inmediata/diagnóstico , Hipersensibilidad Inmediata/fisiopatología , Masculino , Oscilometría/métodos , Estudios Prospectivos , Espirometría/métodos , Resultado del Tratamiento
2.
J Asthma ; 58(10): 1278-1284, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-32597339

RESUMEN

OBJECTIVE: Air pollution is associated with the prevalence of respiratory diseases. This study aimed to evaluate the impacts of outdoor air pollutants and indoor Dermatophagoides pteronyssinus 1 (Der p 1) exposure on levels of fractional exhaled nitric oxide (FeNO), exhaled breath condensate (EBC) pH, and pulmonary function in atopic children. METHODS: This study recruited 59 atopic mild-to-moderate asthmatic children and 23 atopic non-asthmatic children. Data on personal characteristics, FeNO, EBC pH, and pulmonary function were collected. Group 1 allergens of Der p 1 were measured on the tops of mattresses and on bedroom floors in the children's homes, and outdoor air pollutant concentrations were estimated from air quality monitoring stations, using the ordinary kriging method. RESULTS: Exposure levels of outdoor air pollutants, except for particulate matter (PM)2.5, for the recruited children met outdoor air quality standards set by the Taiwan Environmental Protection Agency. The lag effect of outdoor PM10 exposure was negatively associated with the forced expiratory volume in one second (FEV1) [(Lag 1: ß=-0.771, p = 0.028), and O3 (Lag 1-7: ß=-2.02, p = 0.04, Lag 1-28: ß=-3.213, p = 0.029)]. Median pulmonary function parameters differed significantly in forced vital capacity (FVC) (p = 0.004) and FEV1 (p = 0.024) values between atopic asthmatic and non-asthmatic children. No association was found between the FeNO/EBC pH level and exposure to Der p 1 allergen and air pollutants in the recruited children. CONCLUSIONS: Outdoor PM10 and O3 exposure was associated with reduction in FEV1 in atopic asthmatic and non-asthmatic children.


Asunto(s)
Contaminantes Atmosféricos/análisis , Contaminación del Aire/análisis , Asma/epidemiología , Hipersensibilidad Inmediata/epidemiología , Pruebas de Función Respiratoria/estadística & datos numéricos , Adolescente , Contaminación del Aire Interior/análisis , Animales , Asma/fisiopatología , Niño , Dermatophagoides pteronyssinus , Femenino , Humanos , Hipersensibilidad Inmediata/fisiopatología , Masculino , Material Particulado/análisis
3.
Pediatr Pulmonol ; 56(1): 34-41, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-32757362

RESUMEN

INTRODUCTION: Epidemiologic studies have found low/absence of atopy in obese asthmatic children, but the association or lack thereof of atopy with disease morbidity, including pulmonary function, in obese asthma is not well understood. We sought to define the association of atopy with pulmonary function in overweight/obese minority children with asthma. METHODS: In a retrospective chart review of 200 predominantly minority children evaluated at an academic Pediatric Asthma Center over 5 years, we compared the prevalence of atopy, defined as ≥ 1 positive skin prick test or serum-specific immunoglobulin E quantification to environmental allergens, and its association with pulmonary function in overweight/obese (body mass index [BMI] > 85th percentile) (n = 99) to healthy-weight children (BMI, 5th-85th percentile for age) (n = 101). RESULTS: In a cohort comprised of 47.5% Hispanics and 39.5% African Americans, 81% of overweight/obese and 74% of healthy-weight children were atopic. While atopic healthy-weight children had lower percent-predicted forced expiratory volume in the first second (FEV1 ) (93 ± 13.6 vs 107% ± 33.2%, P = .03) and lower percent-predicted forced vital capacity (FVC) (93% ± 12.2% vs 104% ± 16.1%, P = .01) as compared to nonatopic children, atopy was not associated with FEV1 (P = .7) or FVC (P = .17) in overweight/obese children. Adjusting for demographic and clinical variables, atopy was found to be an independent predictor of FEV1 and FVC in healthy-weight (ß = -2.4, P = .07 and ß = -1.7, P = .04, respectively) but not in overweight/obese children (ß = .6, P = .5 and ß = .8, P = .3). CONCLUSIONS: Atopy is associated with lower lung function in healthy-weight asthmatics but not in overweight/obese asthmatics, supporting the role of nonallergic mechanisms in disease burden in pediatric obesity-related asthma.


Asunto(s)
Asma/fisiopatología , Pulmón/fisiopatología , Obesidad Infantil/fisiopatología , Adolescente , Negro o Afroamericano , Alérgenos , Índice de Masa Corporal , Niño , Femenino , Volumen Espiratorio Forzado , Hispánicos o Latinos , Humanos , Hipersensibilidad Inmediata/fisiopatología , Inmunoglobulina E , Masculino , Sobrepeso/epidemiología , Pruebas de Función Respiratoria , Estudios Retrospectivos , Pruebas Cutáneas , Capacidad Vital
4.
Allergy Asthma Proc ; 41(3): 158-166, 2020 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-32375959

RESUMEN

Background: Recent studies demonstrated that, in the past few years, the number of jellyfish species is increasing worldwide; this increase can be explained by environmental and climatic reasons. Contacts with jellyfish can cause acute and chronic effects, including allergic reactions. Although anaphylaxis caused by jellyfish is a rare event, repetitive stings during bathing as well as marine sports and job activities represent important risk factors that can increase the probability of sensitization. Recently, it was also pointed out the possibility of anaphylaxis caused by jellyfish ingestion. In these cases, the sensitization could also be related to previous stings. In cases in which there is no history of jellyfish contact or ingestion, it has been hypothesized that there is a sensitization to an unknown cross-reactive antigen. Objective: The purpose of this work was to collect and review published studies and cases of anaphylaxis associated with jellyfish. Methods: We performed a medical literature data base search, which included English language articles published until September 2019, by using the key words "jellyfish" associated with "anaphylaxis" or "anaphylactic shock." Results: The results of our research showed that dangerous reactions can be caused both by contact and ingestion. Moreover, the latest changes in food habits, life style, and globalization could lead to a more frequent exposure to jellyfish both by contact and ingestion, and, consequently, to a higher probability of sensitization. Conclusion: Prospective studies and well-structured research are needed to better understand all the potential immunologic elements of jellyfish, to clarify its role in sensitization, and to avoid possible dangerous allergic reactions caused by cross-reactivity.


Asunto(s)
Anafilaxia/fisiopatología , Mordeduras y Picaduras/inmunología , Venenos de Cnidarios/inmunología , Ingestión de Alimentos , Hidrozoos/inmunología , Hipersensibilidad Tardía/fisiopatología , Escifozoos/inmunología , Anafilaxia/inmunología , Animales , Humanos , Hipersensibilidad Tardía/inmunología , Hipersensibilidad Inmediata/inmunología , Hipersensibilidad Inmediata/fisiopatología , Inmunización
5.
Chest ; 158(6): 2333-2345, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-32450244

RESUMEN

BACKGROUND: Little is known about the concordance of atopy with asthma COPD overlap. Among individuals with COPD, a better understanding of the phenotypes characterized by asthma overlap and atopy is needed to better target therapies. RESEARCH QUESTION: What is the overlap between atopy and asthma status among individuals with COPD, and how are categories defined by the presence of atopy and asthma status associated with clinical and radiologic phenotypes and outcomes in the Genetic Epidemiology of COPD Study (COPDGene) and Subpopulation and Intermediate Outcome Measures in COPD Study (SPIROMICS)? STUDY DESIGN AND METHODS: Four hundred three individuals with COPD from SPIROMICS and 696 individuals from COPDGene with data about specific IgEs to 10 common allergens and mixes (simultaneous assessment of combination of allergens in similar category) were included. Comparison groups were defined by atopic and asthma status (neither, atopy alone, atopic asthma, nonatopic asthma, with atopy defined as any positive specific IgE (≥0.35 KU/L) to any of the 10 allergens or mixes and asthma defined as self-report of doctor-diagnosed current asthma). Multivariable regression analyses (linear, logistic, and zero inflated negative binomial where appropriate) adjusted for age, sex, race, lung function, smoking status, pack-years smoked, and use of inhaled corticosteroids were used to determine characteristics of groups and relationship with outcomes (exacerbations, clinical outcomes, CT metrics) separately in COPDGene and SPIROMICS, and then adjusted results were combined using meta-analysis. RESULTS: The prevalence of atopy was 35% and 36% in COPD subjects from SPIROMICS and COPDGene, respectively, and less than 50% overlap was seen between atopic status with asthma in both cohorts. In meta-analysis, individuals with nonatopic asthma had the most impaired symptom scores (effect size for St. George's Respiratory Questionnaire total score, 4.2; 95% CI, 0.4-7.9; effect size for COPD Assessment Test score, 2.8; 95% CI, 0.089-5.4), highest risk for exacerbations (incidence rate ratio, 1.41; 95% CI, 1.05-1.88) compared with the group without atopy or asthma. Those with atopy and atopic asthma were not at increased risk for adverse outcomes. INTERPRETATION: Asthma and atopy had incomplete overlap among former and current smokers with COPD in COPDGene and SPIROMICS. Nonatopic asthma was associated with adverse outcomes and exacerbation risk in COPD, whereas groups having atopy alone and atopic asthma had less risk.


Asunto(s)
Síndrome de Superposición de la Enfermedad Pulmonar Obstructiva Crónica-Asmática , Hipersensibilidad Inmediata , Inmunoglobulina E , Enfermedad Pulmonar Obstructiva Crónica , Estado Asmático , Síndrome de Superposición de la Enfermedad Pulmonar Obstructiva Crónica-Asmática/epidemiología , Síndrome de Superposición de la Enfermedad Pulmonar Obstructiva Crónica-Asmática/inmunología , Síndrome de Superposición de la Enfermedad Pulmonar Obstructiva Crónica-Asmática/fisiopatología , Síndrome de Superposición de la Enfermedad Pulmonar Obstructiva Crónica-Asmática/terapia , Variación Biológica Poblacional , Manejo de la Enfermedad , Femenino , Humanos , Hipersensibilidad Inmediata/epidemiología , Hipersensibilidad Inmediata/fisiopatología , Inmunoglobulina E/análisis , Inmunoglobulina E/clasificación , Masculino , Persona de Mediana Edad , Epidemiología Molecular , Prevalencia , Enfermedad Pulmonar Obstructiva Crónica/epidemiología , Enfermedad Pulmonar Obstructiva Crónica/genética , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Enfermedad Pulmonar Obstructiva Crónica/terapia , Factores de Riesgo , Fumar/epidemiología , Estado Asmático/epidemiología , Estado Asmático/inmunología
6.
Toxicol Appl Pharmacol ; 395: 114981, 2020 05 15.
Artículo en Inglés | MEDLINE | ID: mdl-32240662

RESUMEN

What factors and underlying mechanisms influence the occurrence of the atopic march remain unclear. Recent studies suggest that exposure to diisononyl phthalate (DINP) might be associated with the occurrence of atopic dermatitis (AD) and asthma. However, little is known about the role of DINP exposure in the atopic march. In this study, we investigated the effect of DINP exposure on the progression from AD to asthma, and explored the potential mechanisms. We built an atopic march mouse model from AD to asthma, by exposure to DINP and sensitization with OVA. Pyrrolidine dithiocarbamate and SB203580 were used to block NF-κB and p38 MAPK respectively, to explore the possible molecular mechanisms. The data showed that DINP aggravated airway remodeling and airway hyperresponsiveness (AhR) in the progression from AD to asthma, induced a sharp increase in IL-33, IgE, Th2 and Th17 cytokines, and resulted in an increase in the expression of thymic stromal lymphopoietin (TSLP) and in the number of inflammatory cells. Blocking NF-κB inhibited AD-like lesions, and the production of IL-33 and TSLP in the progression of AD, while alleviating airway remodeling, AhR, and the expression of Th2 and Th17 cytokines in both the progression of AD and the asthmatic phenotype. Blocking p38 MAPK in the progression of asthma, inhibited airway remodeling, AhR, and the expression of Th2 and Th17 cytokines. The results demonstrated that exposure to DINP enhanced the immune response to memory CD4+ T helper cells through the NF-κB and p38 MAPK signaling pathways, leading to an aggravation of the atopic march.


Asunto(s)
Hipersensibilidad Inmediata/inducido químicamente , FN-kappa B/fisiología , Ácidos Ftálicos/toxicidad , Proteínas Quinasas p38 Activadas por Mitógenos/fisiología , Remodelación de las Vías Aéreas (Respiratorias)/efectos de los fármacos , Animales , Asma/inducido químicamente , Citocinas/biosíntesis , Dermatitis Atópica/inducido químicamente , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Activación Enzimática/efectos de los fármacos , Hipersensibilidad Inmediata/inmunología , Hipersensibilidad Inmediata/fisiopatología , Masculino , Ratones , Ratones Endogámicos BALB C , FN-kappa B/antagonistas & inhibidores , Ovalbúmina/inmunología , Hipersensibilidad Respiratoria/inducido químicamente , Transducción de Señal/efectos de los fármacos , Organismos Libres de Patógenos Específicos , Células Th17/inmunología , Células Th2/inmunología , Proteínas Quinasas p38 Activadas por Mitógenos/antagonistas & inhibidores , Linfopoyetina del Estroma Tímico
7.
Dermatitis ; 31(3): 185-190, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32217881

RESUMEN

: Wine, beer, liquor, and spirits are widely consumed in many cultures across the globe, and for some individuals, ingestion, cutaneous contact, or other exposure can lead to dermatologic findings. However, there currently exist no comprehensive reviews on alcohol-related dermatitis. Herein, we will provide an overview of alcohol-related dermatitis and contact urticaria, including the epidemiology and clinical manifestations, potential allergens found in alcoholic beverages, testing approaches, and strategies for allergen avoidance.


Asunto(s)
Bebidas Alcohólicas/efectos adversos , Dermatitis Alérgica por Contacto/epidemiología , Urticaria/epidemiología , Bálsamos/efectos adversos , Cerveza/efectos adversos , Cromo/efectos adversos , Citrus/efectos adversos , Cobalto/efectos adversos , Dermatitis/epidemiología , Dermatitis/fisiopatología , Dermatitis/terapia , Dermatitis Alérgica por Contacto/etiología , Dermatitis Alérgica por Contacto/fisiopatología , Dermatitis Alérgica por Contacto/terapia , Conservantes de Alimentos/efectos adversos , Oro/efectos adversos , Humanos , Hipersensibilidad Tardía/epidemiología , Hipersensibilidad Tardía/etiología , Hipersensibilidad Tardía/fisiopatología , Hipersensibilidad Tardía/terapia , Hipersensibilidad Inmediata/epidemiología , Hipersensibilidad Inmediata/etiología , Hipersensibilidad Inmediata/fisiopatología , Hipersensibilidad Inmediata/terapia , Isotiocianatos/efectos adversos , Níquel/efectos adversos , Propilenglicol/efectos adversos , Sulfitos/efectos adversos , Urticaria/etiología , Urticaria/fisiopatología , Urticaria/terapia , Vino/efectos adversos
8.
PLoS One ; 14(8): e0220198, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31415591

RESUMEN

BACKGROUND: Chronic systemic inflammation accelerates early vascular ageing. Atopic sensitization and allergic diseases may involve increased inflammatory activity. This study aimed to assess whether atopic sensitization and allergic diseases were associated with altered vascular biomarkers in Norwegian adolescents. METHODS: Distensibility coefficient of the common carotid arteries, carotid intima-media thickness and atopic sensitization (serum total and specific IgEs) were assessed in 95 Norwegian adolescents, who participated in the RHINESSA generation study. Symptoms of allergic disease were assessed by an interviewer-led questionnaire. RESULTS: Atopic sensitization was found in 33 (34.7%) of the adolescents. Symptomatic allergic disease was found in 11 (33.3%) of those with atopic sensitization. Distensibility coefficient of the common carotid arteries appeared to be lower in participants with atopic sensitization than in those without (46.99±8.07*10-3/kPa versus 51.50±11.46*10-3/kPa; p>0.05), while carotid intima-media thickness did not differ between these groups (0.50±0.04mm versus 0.50±0.04mm; p>0.05). Crude, as well as age- and sex-adjusted multiple regression, revealed no significant association, neither of atopic sensitization nor of allergic disease, with distensibility coefficient of the common carotid arteries and carotid intima-media thickness. CONCLUSIONS: Our results do not support the assumption of an adverse impact of atopic sensitization and/or allergic disease on distensibility coefficient of the common carotid arteries and carotid intima-media thickness in Norwegian adolescents. Further research is necessary to study whether the clinical severity of allergic diseases might be more important than the status of allergic disease or atopic sensitization.


Asunto(s)
Vasos Sanguíneos/metabolismo , Hipersensibilidad Inmediata/fisiopatología , Adolescente , Biomarcadores/metabolismo , Vasos Sanguíneos/diagnóstico por imagen , Vasos Sanguíneos/fisiopatología , Grosor Intima-Media Carotídeo , Femenino , Humanos , Hipersensibilidad Inmediata/diagnóstico por imagen , Hipersensibilidad Inmediata/metabolismo , Masculino , Encuestas y Cuestionarios , Factores de Tiempo
9.
Pediatr Allergy Immunol ; 30(7): 708-715, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31322788

RESUMEN

BACKGROUND: The definitions of childhood asthma differ among epidemiological studies. We aimed to compare the diagnostic accuracy and agreement of previous asthma definitions and to evaluate questionnaire-driven asthma definition patterns. METHODS: Data on 808 participants aged 7-12 years from 20 schools were analyzed. Asthma definitions based on symptoms assessed by questionnaire, parent-reported medical asthma diagnosis, current use of asthma medication, airway reversibility after bronchodilatation, and increased (≥35 ppb) levels of exhaled nitric oxide (eNO) were compared with a gold standard (medical diagnosis of asthma with asthma symptoms in the past 12 months and/or airway reversibility). Concordance was assessed by Cohen's kappa. Data-driven analysis was applied to the questionnaire, and six scores were determined "asthma," "rhinitis," "cough," "non-specific respiratory symptoms," "treated asthma," and "uncontrolled asthma." Tree decisions were built using these scores. RESULTS: Definitions of asthma based on respiratory symptoms, airway reversibility, and parent-reported medical diagnosis had a low sensitivity but high specificity. Agreement between reported and objective measures was poor. Parent-reported medical asthma diagnosis, but not reversibility or eNO, was able to predict questionnaire-driven symptom patterns. Decision trees indicated that those with recent non-specific respiratory symptoms had a higher probability of positive bronchodilation. CONCLUSION: A standardized operational definition of asthma should include a composite score based on reported asthma medical diagnosis, symptoms, and lung function.


Asunto(s)
Asma/diagnóstico , Asma/epidemiología , Antiasmáticos/uso terapéutico , Asma/fisiopatología , Broncodilatadores/farmacología , Niño , Estudios Transversales , Árboles de Decisión , Espiración , Femenino , Volumen Espiratorio Forzado , Humanos , Hipersensibilidad Inmediata/diagnóstico , Hipersensibilidad Inmediata/epidemiología , Hipersensibilidad Inmediata/fisiopatología , Masculino , Óxido Nítrico/metabolismo , Portugal/epidemiología , Valor Predictivo de las Pruebas , Pruebas de Función Respiratoria , Encuestas y Cuestionarios
11.
Immun Inflamm Dis ; 7(3): 150-159, 2019 09.
Artículo en Inglés | MEDLINE | ID: mdl-31251481

RESUMEN

BACKGROUND: Microfibrillar-associated protein 4 (MFAP4) is an extracellular matrix protein belonging to the fibrinogen-related protein superfamily, which plays multifaceted roles in innate immunity and normal endothelial function. It has been proposed that MFAP4 promotes the development of asthma in vivo and proasthmatic pathways of bronchial smooth muscle cells in vitro. The aim of this study was to investigate the significance of serum MFAP4 in adolescents and young adolescents with persistent asthma. METHODS: Prospective, observational study including adolescents and young adults (age 11-27 years) previously diagnosed with asthma during childhood 2003 to 2005 (0-15 years) at the four pediatric outpatient clinics in the Region of Southern Denmark (n = 449). Healthy controls were recruited at follow-up (n = 314). Detection of serum MFAP4 was performed by AlphaLISA technique. RESULTS: Current asthma was associated to a 14% higher mean level of serum MFAP4 compared with controls (expß 1.14, 95% confidence intervals [CI], 1.05-1.23) and a 6% higher mean level compared with subjects with no current asthma (expß 1.06, 95% CI, 0.99-1.13). No association was found at follow-up between serum MFAP4 and self-reported atopic symptoms (other than asthma), Asthma Control Test-score, fractional exhaled nitric oxide (FeNO), nor to flow rate at 1 second, forced vital capacity, and forced expiratory flow 25% to 75%, response to short-acting beta 2 agonist or mannitol. CONCLUSIONS: We found a significantly higher mean level of serum MFAP4 in adolescent and young adults with mild to moderate asthma compared with healthy controls but no association to FeNO and lung function nor to the response to short-acting beta 2 agonist or mannitol. The result supports the hypothesis that MFAP4 plays a role in the pathogenesis of asthma although the marker did not demonstrate any obvious potential as an asthma biomarker in adolescents and young adults with asthma. To understand the possible proasthmatic functions of MFAP4, further investigation in specific asthma phenotypes and the underlying molecular mechanisms is warranted.


Asunto(s)
Asma/sangre , Proteínas Portadoras/sangre , Proteínas de la Matriz Extracelular/sangre , Glicoproteínas/sangre , Hipersensibilidad Inmediata/sangre , Óxido Nítrico/análisis , Adolescente , Adulto , Asma/fisiopatología , Niño , Dinamarca , Espiración , Femenino , Humanos , Hipersensibilidad Inmediata/diagnóstico , Hipersensibilidad Inmediata/fisiopatología , Masculino , Estudios Prospectivos , Capacidad Vital , Adulto Joven
12.
J Allergy Clin Immunol Pract ; 7(4): 1109-1114, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30961836

RESUMEN

Mast cell activation syndrome (MCAS) is a rare condition defined by a severe systemic reaction to mast cell (MC)-derived mediators. Most cases present with clinical signs of anaphylaxis, and some have an underlying IgE-dependent allergy. A primary MC disease (mastocytosis) may also be detected. Severe recurrent MCAS episodes requiring intensive care or even resuscitation are typically found in patients who suffer from both mastocytosis and allergy against certain triggers, such as hymenoptera venom components. A less severe form and a local form of MC activation (MCA) also exist. For these patients, diagnostic criteria are lacking. Moreover, a number of different, unrelated, conditions with overlapping symptoms may be confused with MCAS. As a result, many patients believe that they are suffering from MCAS but have in fact a less severe form of MCA or another underlying disease. In the current article, we review the potential differential diagnoses of MCA and MCAS and discuss available diagnostic criteria and diagnostic tools. These criteria and assays may be useful in daily practice and help avoid unnecessary referrals and unjustified fears in patients.


Asunto(s)
Diagnóstico Diferencial , Mastocitosis/diagnóstico , Anafilaxia/fisiopatología , Humanos , Hipersensibilidad Inmediata/diagnóstico , Hipersensibilidad Inmediata/fisiopatología , Mastocitos/inmunología , Mastocitosis/inmunología , Mastocitosis/fisiopatología , Proteínas Proto-Oncogénicas c-kit/genética , Triptasas/metabolismo
13.
Med Sci Sports Exerc ; 51(8): 1582-1590, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-30913162

RESUMEN

INTRODUCTION: Owing to its well-established ergogenic potential, creatine is a highly popular food supplement in sports. As an oral supplement, creatine is considered safe and ethical. However, no data exist on the safety of creatine on lung function in athletes. The aim of this project was to evaluate the effects of a standard course of creatine on the airways of youth elite athletes. METHODS: Nineteen elite soccer players, 16-21 yr old, completed a stratified, randomized, double-blind, placebo-controlled, parallel-group trial. The creatine group (n = 9) ingested 0.3 g·kg⋅d of creatine monohydrate (CM) for 1 wk (loading phase) and 5 g·d for 7 wk (maintenance phase), and the placebo group (n = 10) received the same dosages of maltodextrin. Airway inflammation (assessed by exhaled nitric oxide, FENO) and airway responsiveness (to dry air hyperpnoea) were measured pre- and postsupplementation. RESULTS: Mild, unfavorable changes in FENO were noticed by trend over the supplementation period in the CM group only (P = 0.056 for interaction, η = 0.199), with a mean group change of 9 ± 13 ppb in the CM group versus -5 ± 16 ppb in the placebo group (P = 0.056, d = 0.695). Further, the maximum fall in forced expiratory volume in 1 s after dry air hyperpnoea was larger by trend postsupplementation in the CM group compared with the placebo group: 9.7% ± 7.5% vs 4.4% ± 1.4%, respectively (P = 0.070, d = 0.975). These adverse effects were more pronounced when atopic players only (n = 15) were considered. CONCLUSION: On the basis of the observed trends and medium to large effect sizes, we cannot exclude that creatine supplementation has an adverse effect on the airways of elite athletes, particularly in those with allergic sensitization. Further safety profiling of the ergogenic food supplement is warranted.


Asunto(s)
Creatina/efectos adversos , Suplementos Dietéticos/efectos adversos , Pulmón/efectos de los fármacos , Sustancias para Mejorar el Rendimiento/efectos adversos , Ventilación Pulmonar/efectos de los fármacos , Fútbol/fisiología , Adolescente , Biomarcadores/análisis , Pruebas Respiratorias , Creatina/administración & dosificación , Método Doble Ciego , Flujo Espiratorio Forzado , Humanos , Hipersensibilidad Inmediata/fisiopatología , Inflamación/inducido químicamente , Mediciones del Volumen Pulmonar , Masculino , Óxido Nítrico/análisis , Sustancias para Mejorar el Rendimiento/administración & dosificación , Acondicionamiento Físico Humano
14.
J Allergy Clin Immunol Pract ; 7(4): 1125-1133.e1, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30737190

RESUMEN

Mast cell activation (MCA) accompanies diverse physiologic and pathologic processes and is one of the more frequently encountered conditions in medicine. MCA-related symptoms are usually mild and often transient. In such cases, histamine receptor blockers and other mediator-targeting drugs can usually control MCA. In severe cases, an MCA syndrome (MCAS) may be diagnosed. However, overt MCAS is an unusual condition, and many patients referred because of suspected MCAS are diagnosed with other diseases (autoimmune, neoplastic, or infectious) unrelated to MCA or suffer from MCA-related (eg, allergic) disorders and/or comorbidities without fulfilling criteria of an overt MCAS. These considerations are important as more and more patients are informed that they may have MCA or even MCAS without completing a thorough medical evaluation. In fact, in several instances, symptoms are misinterpreted as MCA/MCAS, and other clinically relevant conditions are not thoroughly pursued. The number of such referrals is increasing. To avoid such unnecessary referrals and to prevent misdiagnoses, we here propose a diagnostic algorithm through which a clinically relevant (systemic) MCA can be suspected and MCAS can subsequently be documented or excluded. In addition, the algorithm proposed should help guide the investigating care providers to consider the 2 principal diagnoses that may underlie MCAS, namely, severe allergy and systemic mastocytosis accompanied by severe MCA. Although validation is required, we anticipate that this algorithm will facilitate the management of patients with suspected MCAS.


Asunto(s)
Algoritmos , Mastocitosis/diagnóstico , Diagnóstico Diferencial , Humanos , Hipersensibilidad Inmediata/diagnóstico , Hipersensibilidad Inmediata/fisiopatología , Mastocitosis/genética , Mastocitosis/metabolismo , Mastocitosis/fisiopatología , Mastocitosis Sistémica/diagnóstico , Mastocitosis Sistémica/fisiopatología , Proteínas Proto-Oncogénicas c-kit/genética , Triptasas/metabolismo
15.
J Allergy Clin Immunol Pract ; 7(5): 1541-1549, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30682574

RESUMEN

BACKGROUND: The rate of true vaccine allergy is unknown. Children with potential IgE-mediated adverse events following immunization (AEFI) should undergo allergy investigation that may include skin testing or challenge. Previous protocols tend to be highly conservative and often suggest invasive testing for all, a practice not evidence based, technically difficult, and unpleasant in children. It has more recently been suggested that skin testing may be restricted to those with allergic-like events within the first hour and those with a history of anaphylaxis. OBJECTIVE: We aimed to describe the outcome of vaccine skin testing and challenge in children referred to a tertiary pediatric hospital with a potential IgE-mediated AEFI. The secondary aim was to identify any significant risk factors for vaccine allergy. METHODS: A retrospective review of all children (<18 years) who underwent vaccine skin testing (skin prick testing or intradermal testing [IDT]) or challenge over a 5-year period (May 1, 2011, to April 30, 2016) at the Royal Children's Hospital Melbourne is presented. RESULTS: There were 95 admissions in 73 children. Eight percent (6 of 73) of children had confirmed vaccine allergy (positive skin testing or challenge to the index vaccination). Two had positive IDT to a suspect vaccine but challenge negative to an alternative brand vaccine. Two had negative IDT but subsequent positive challenge and two had immediate urticaria on challenge without prior skin testing. All children in the positive group either had index reaction within 15 minutes of vaccination or had history consistent with anaphylaxis. CONCLUSIONS: The vast majority of children (92%) presenting with a potential IgE-mediated AEFI are able to tolerate challenge to a suspect vaccine without reaction. We present our investigation protocol recommending skin testing in all children with anaphylaxis and challenge with a suspect vaccine if negative testing or previous nonanaphylactic potential IgE-mediated AEFI.


Asunto(s)
Hipersensibilidad Inmediata/diagnóstico , Factores Inmunológicos/efectos adversos , Vacunas/efectos adversos , Adolescente , Anafilaxia/diagnóstico , Anafilaxia/etiología , Anafilaxia/fisiopatología , Angioedema/diagnóstico , Angioedema/etiología , Angioedema/fisiopatología , Australia , Niño , Preescolar , Vacuna contra Difteria, Tétanos y Tos Ferina/efectos adversos , Vacunas contra Difteria, Tétanos y Tos Ferina Acelular/efectos adversos , Femenino , Vacunas contra Haemophilus/efectos adversos , Vacunas contra la Hepatitis A/efectos adversos , Vacunas contra Hepatitis B/efectos adversos , Hospitales Pediátricos , Humanos , Hipersensibilidad Inmediata/etiología , Hipersensibilidad Inmediata/fisiopatología , Lactante , Vacunas contra la Influenza/efectos adversos , Pruebas Intradérmicas , Masculino , Vacuna contra el Sarampión-Parotiditis-Rubéola/efectos adversos , Vacunas contra Papillomavirus/efectos adversos , Vacunas Neumococicas/efectos adversos , Vacuna Antipolio de Virus Inactivados/efectos adversos , Polisacáridos Bacterianos/efectos adversos , Estudios Retrospectivos , Vacunas contra Rotavirus/efectos adversos , Pruebas Cutáneas , Centros de Atención Terciaria , Factores de Tiempo , Vacunas Tifoides-Paratifoides/efectos adversos , Urticaria/diagnóstico , Urticaria/etiología , Urticaria/fisiopatología , Vacunas Atenuadas/efectos adversos , Vacunas Combinadas/efectos adversos
16.
Saudi Med J ; 39(7): 662-667, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29968887

RESUMEN

OBJECTIVES: To investigate the correlation between Interleukin 17 (IL-17F) and the level of asthma control. METHODS: This is a cross-sectional study of 40 subjects who were diagnosed with atopic asthma. All participants were recruited from the Allergy and Immunology Clinic, Prof. R.D. Kandou General Hospital, Manado, Indonesia, between April 2015 and April 2016. Total serum IL-17F measured by using Enzyme-Linked Immunosorbent Assay methods; and mRNA IL-17F was obtained by using real-time reverse transcriptase polymerase chain reaction. Level of asthma control was quantified by using asthma control test (ACT) scoring system. The correlation between IL-17F, mRNA, and level of asthma control was analyzed by using Pearson's correlation coefficient (r). RESULTS: There is a strong positive correlation between IL-17F serum level and Nathan's ACT-score (r=0.969) which is statistically significant (p less than 0.001). Analysis of the correlation between mRNA IL-17F serum level and Nathan's ACT-score revealed a strong positive correlation (r=0.963), which is statistically significant (p less than 0.001). CONCLUSION: These findings suggest that IL-17F plays an important role in asthma control. However, the role played by IL-17F in asthma pathogenesis are still questions to be answered.


Asunto(s)
Asma/genética , Hipersensibilidad Inmediata/genética , Interleucina-17/genética , ARN Mensajero/metabolismo , Adulto , Asma/tratamiento farmacológico , Asma/metabolismo , Asma/fisiopatología , Estudios Transversales , Femenino , Humanos , Hipersensibilidad Inmediata/tratamiento farmacológico , Hipersensibilidad Inmediata/metabolismo , Hipersensibilidad Inmediata/fisiopatología , Interleucina-17/metabolismo , Masculino , Persona de Mediana Edad , Pronóstico , Reacción en Cadena en Tiempo Real de la Polimerasa , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Adulto Joven
17.
Eur J Ophthalmol ; 28(5): 598-606, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29756485

RESUMEN

INTRODUCTION: Previous studies have suggested associations between glaucoma and serum sensitization to specific allergens. The purpose of this study was to examine associations between inciting factors for atopic disease, atopic diseases and symptoms, and glaucoma in the 2005-2006 National Health and Nutrition Examination Survey. METHODS: The study population included adult participants of National Health and Nutrition Examination Survey 2005-2006. Inciting factors for atopic disease included pet ownership, mildew/musty smell in home, cockroaches in home, use of water treatment devices, and crowded living conditions. Atopic diseases and symptoms included hay fever, eczema, any allergy, sneezing problems, and sinus infections. The outcome was glaucoma defined by the Rotterdam criteria. Covariates included age, gender, ethnicity, and allergy-related medication use. Logistic regression was used to examine associations between each exposure and glaucoma prevalence, controlling for all covariates. Statistical analyses were weighted by the National Health and Nutrition Examination Survey multistage sampling design. RESULTS: The weighted study population included 83,205,587 subjects, of whom 2,657,336 (3.2%) had glaucoma. After adjusting for covariates, factors associated with increased glaucoma included cat ownership (odds ratio =1.99, 95% confidence interval = 1.02-3.87) and mildew/musty smell in home (odds ratio = 1.95, 95% confidence interval = 0.99-3.84; borderline significance), while history of eczema was associated with decreased glaucoma (odds ratio = 0.27, 95% confidence interval = 0.02-0.99). CONCLUSION: In National Health and Nutrition Examination Survey, self-reported cat ownership is associated with increased glaucoma prevalence, while a mildew/musty smell in home may have a borderline association with increased glaucoma prevalence. These findings are possibly related to laboratory associations identified in the same population and further studies are needed to identify potential mechanisms to explain these associations.


Asunto(s)
Alérgenos/efectos adversos , Glaucoma de Ángulo Abierto/epidemiología , Hipersensibilidad Inmediata/epidemiología , Encuestas Nutricionales , Estudios Transversales , Femenino , Glaucoma de Ángulo Abierto/fisiopatología , Humanos , Hipersensibilidad Inmediata/fisiopatología , Modelos Logísticos , Masculino , Persona de Mediana Edad , Encuestas Nutricionales/estadística & datos numéricos , Oportunidad Relativa , Prevalencia , Estudios Retrospectivos , Factores de Riesgo , Estados Unidos/epidemiología
18.
Sci Rep ; 8(1): 3572, 2018 02 23.
Artículo en Inglés | MEDLINE | ID: mdl-29476121

RESUMEN

Among traditional Chinese medicine injections, intravenous Shuang-Huang-Lian (IV-SHL) has the highest incidence of injection-induced immediate hypersensitivity reactions (IHRs). The precise mechanisms of IV-SHL-induced IHRs remain ambiguous. In this study, we investigated the mechanisms of SHL injection (SHLI)-induced IHRs. Our data showed that serum total IgE and mouse mast cell protease 1 (MMCP1) levels were higher in the SHLI antiserum; however, these effects of SHLI disappeared in the antibiotic-treated mice. SHLI caused intraplantar vasopermeability and shock during the first local or systemic injection. SHLI-induced nonallergic IHRs were attributed to its intermediate fraction F2 (the extract of Lonicerae Japonicae Flos and Fructus forsythiae), and could be blocked by antagonists for histamine or C5a, rather than PAF or C3a. Eight constituents of F2 were able to directly activate C5 to promote local vasopermeability at the mg/mL level. In conclusion, SHLI-induced IHRs are not mediated by IgE. SHLI or its F2 can directly activate blood C5. Subsequently, C5a is likely to provoke histamine release from its effector cells (e.g., mast cells and basophils), indicating that histamine is a principal effector of IHRs induced by SHLI.


Asunto(s)
Complemento C5a/genética , Medicamentos Herbarios Chinos/efectos adversos , Hipersensibilidad Inmediata/genética , Medicina Tradicional China , Animales , Antibacterianos/administración & dosificación , Basófilos/efectos de los fármacos , Cromatografía Líquida de Alta Presión , Quimasas/sangre , Medicamentos Herbarios Chinos/administración & dosificación , Histamina/biosíntesis , Humanos , Hipersensibilidad Inmediata/sangre , Hipersensibilidad Inmediata/inducido químicamente , Hipersensibilidad Inmediata/fisiopatología , Inmunoglobulina E/sangre , Lonicera/química , Ratones , Scutellaria baicalensis/química
19.
Pediatr Pulmonol ; 53(2): 130-137, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29265553

RESUMEN

OBJECTIVE: To examine the associations of maternal hemoglobin and hematocrit levels during pregnancy with childhood lung function and asthma, and whether adverse pregnancy outcomes and atopic predisposition modify the associations. METHODS: In a population-based prospective cohort study among 3672 subjects, we measured maternal hemoglobin and hematocrit levels in early pregnancy, and lung function by spirometry and current asthma by questionnaire at age 10 years. RESULTS: Higher maternal hematocrit levels, both continuously and categorized into clinical cut-offs, were associated with lower forced expiratory flow at 75% of forced vital capacity (FEF75 ) in children (Z-score (95%CI): -0.04 (-0.07, -0.01), per increase of 1 SDS in hematocrit level; Z-score (95%CI) difference: -0.11 (-0.20, -0.03) compared with normal hematocrit levels, respectively), taking lifestyle and socio-economic factors into account. Adverse pregnancy outcomes and atopic predisposition did not modify the results. No associations of maternal hemoglobin and hematocrit with current asthma were observed. CONCLUSION: Higher maternal hematocrit levels during pregnancy are associated with lower childhood lung function but not with risk of asthma. Adverse pregnancy outcomes and atopic predisposition do not modify these associations. Underlying mechanisms need to be further studied.


Asunto(s)
Asma/fisiopatología , Hematócrito , Hemoglobinas/metabolismo , Pulmón/fisiopatología , Embarazo/sangre , Efectos Tardíos de la Exposición Prenatal , Adulto , Anemia/fisiopatología , Niño , Femenino , Humanos , Hipersensibilidad Inmediata/fisiopatología , Estilo de Vida , Estudios Longitudinales , Complicaciones Hematológicas del Embarazo/fisiopatología , Resultado del Embarazo , Estudios Prospectivos , Factores de Riesgo , Factores Socioeconómicos , Espirometría , Encuestas y Cuestionarios , Capacidad Vital
20.
J Allergy Clin Immunol Pract ; 6(3): 865-871, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29175370

RESUMEN

BACKGROUND: Asthma in the elderly population (60 years of age and older) is frequently underdiagnosed, as well as atopy. Atopy, although more prevalent in younger patients, can be a major cause of asthma in the elderly. Chronic obstructive pulmonary disease (COPD) and cardiovascular disease are common differential diagnoses, especially in elderly smokers. OBJECTIVE: The objective of this study was to assess atopy and comorbidities in elderly patients with asthma. METHODS: This was an observational and retrospective study involving elderly asthmatic patients followed up at a tertiary center. Patients were assessed for severity of asthma, frequency of atopy, and frequency of comorbidities concomitant with asthma. Then, they were classified according to their age at asthma onset and the groups compared with each other for atopy, spirometric parameters, and comorbidities. RESULTS: This study included 243 elderly asthmatic patients, 71.8% of them presenting severe disease and 82.3% forced expiratory volume in 1 second (FEV1) < 80%. Gastroesophageal reflux disease, obesity, and asthma-COPD overlap syndrome were observed, respectively, in 64%, 37%, and 13% of these patients. Atopy was observed in 63%, mainly in those with early onset disease, and its frequency decreased as the age of asthma onset increased (P < .05). Total serum IgE was higher for allergic patients and FEV1 values were lower for patients with long-term asthma. Aspirin-exacerbated respiratory disease was more frequent in patients with nonallergic asthma. CONCLUSIONS: Most elderly asthmatic patients followed up in our tertiary center were atopic and higher values of total serum IgE suggest atopy. Atopy was inversely correlated with age of asthma onset. The diagnosis of allergic asthma in the elderly population is essential to treat patients more properly, improving their quality of life and decreasing asthma morbidity and mortality.


Asunto(s)
Asma/diagnóstico , Hipersensibilidad Inmediata/diagnóstico , Adolescente , Adulto , Edad de Inicio , Anciano , Alérgenos/inmunología , Asma/sangre , Asma/epidemiología , Asma/fisiopatología , Niño , Comorbilidad , Femenino , Volumen Espiratorio Forzado , Humanos , Hipersensibilidad Inmediata/sangre , Hipersensibilidad Inmediata/epidemiología , Hipersensibilidad Inmediata/fisiopatología , Inmunoglobulina E/sangre , Masculino , Persona de Mediana Edad , Pruebas Cutáneas , Capacidad Vital , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...